Hydatidiform Mole in Turkey: Results From Six Centers
dc.contributor.author | Öge, T. | |
dc.contributor.author | Sinan Özalp, S. | |
dc.contributor.author | Güngör, T. | |
dc.contributor.author | Yıldırım, Y. | |
dc.contributor.author | Sancı, M. | |
dc.contributor.author | Doğan, A. | |
dc.contributor.author | Egemen Ertaş, I. | |
dc.date.accessioned | 2020-03-26T18:32:48Z | |
dc.date.available | 2020-03-26T18:32:48Z | |
dc.date.issued | 2012 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Objective: To evaluate the clinical profile of gestational trophoblastic disease and to determine the incidence of hydatidiform mole (HM) from six centers in Turkey. Study Design: A retrospective analysis of patients diagnosed with HM in six medical centers in Turkey from 2000 to 2010 was undertaken. Patients' age, gravidity, parity and abortion, presenting signs, histopathological results and their follow-up were recorded. Results: From 2000 to 2010, 351,650 deliveries were recorded in six centers in Turkey, and 263 cases were diagnosed as HMs. Of the 263 patients the mean age was 28.2 years. The mean numbers of gravidity, parity and abortion were 2.6, 1.3 and 0.3, respectively. According to the medical histories, 3 (1.1%) patients had molar pregnancy previously and the presenting symptom was vaginal bleeding in symptomatic cases. After evacuation, histopathologic examination revealed complete mole in 175 (66.5%) patients and partial mole in 86 (32.6%) patients, and methotrexate was given as a prophylactic chemotherapy in 17 patients (6.4%) while 6 (2.2%) patients underwent hysterectomy procedure. Conclusion: According to the results the incidence of molar pregnancy is 0.7/1,000 deliveries. Because of its rarity, multicenter, community-based studies are needed to determine the real incidence. © Journal of Reproductive Medicine®, Inc. | en_US |
dc.identifier.citation | Öge, T., Sinan Özalp, S., Güngör, T., Yıldırım, Y., Sancı, M., Doğan, A., Egemen Ertaş, I., (2012). Hydatidiform Mole in Turkey: Results From Six Centers. Journal of Reproductive Medicine, 57, 259-261. | |
dc.identifier.endpage | 261 | en_US |
dc.identifier.issn | 0024-7758 | en_US |
dc.identifier.issue | 05.06.2020 | en_US |
dc.identifier.pmid | 22696823 | en_US |
dc.identifier.scopusquality | Q4 | en_US |
dc.identifier.startpage | 259 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/28777 | |
dc.identifier.volume | 57 | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of Reproductive Medicine | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Demographic and health surveys | en_US |
dc.subject | Gestational trophoblastic disease | en_US |
dc.subject | Hydatidiform mole | en_US |
dc.title | Hydatidiform Mole in Turkey: Results From Six Centers | en_US |
dc.type | Article | en_US |